MLYS
Mineralys Therapeutics, Inc. · Healthcare · Market cap $1.9B
Insiders sold $5.7M net in the last 90 days ·5 sellers, 0 buyers· 6 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$8.8M
reported purchases (SEC code P)
Insider Selling
$88.0M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 20, 2026
Congleton Jon
Mineralys Therapeutics, Inc. (MLYS) has 56 SEC Form 4 filings (160 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 20, 2026.
Inside the rolling window, 8 insiders at Mineralys Therapeutics, Inc. reported 2 open-market purchases totaling $8.8M and 54 open-market sales totaling $88.0M. The most active filer is Chief Medical Officer Rodman David Malcom with 32 filings. Insiders have net sold $12.5M over the trailing 6 months. The most recent open-market filing is a sale of 75,000 shares by Chief Executive Officer Congleton Jon, dated Sep 30, 2026, worth $1.9M.
- Industry:Biotechnology
- CEO:Jon Congleton
- Employees:76
- HQ:Radnor, PA, US
- IPO:2023-02-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 75,000 | $1.9M | Oct 2 | -9.1% | SEC ↗ | |
Slingsby Brian TaylorFirst in 10 months | Director | Sale | 104,320 | $3.0M | Sep 25 | -17.0% | SEC ↗ |
| Chief Commercial Officer | Sale | 7,438 | $209K | Sep 22 | -20.2% | SEC ↗ | |
Karydas DaphneFirst in 3 months | Director | Sale | 3,000 | $86K | Sep 17 | -23.3% | SEC ↗ |
| Chief Commercial Officer | Sale | 7,437 | $193K | Aug 25 | -18.5% | SEC ↗ | |
| Chief Medical Officer | Sale | 2,170 | $59K | Aug 12 | -20.6% | SEC ↗ | |
| Chief Commercial Officer | Sale | 7,438 | $200K | Jul 23 | -20.5% | SEC ↗ | |
| Chief Medical Officer | Sale | 416 | $11K | Jul 21 | -22.0% | SEC ↗ | |
| Chief Executive Officer | Sale | 10,700 | $291K | Jul 16 | -20.7% | SEC ↗ | |
| Chief Medical Officer | Sale | 14,058 | $388K | Jul 16 | -20.7% | SEC ↗ | |
| Chief Medical Officer | Sale | 6,349 | $169K | Jul 16 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 2,171 | $66K | Jul 10 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 75,000 | $2.0M | Jun 30 | — | SEC ↗ | |
Warren EricFirst filing | Chief Commercial Officer | Sale | 104,124 | $2.7M | Jun 30 | — | SEC ↗ |
| Chief Medical Officer | Sale | 9,890 | $235K | Jun 18 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 4,584 | $115K | Jun 18 | — | SEC ↗ | |
| Director | Sale | 3,000 | $75K | Jun 18 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 2,170 | $54K | Jun 12 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 6,349 | $152K | Jun 12 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 417 | $11K | May 19 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 2,171 | $65K | May 14 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 6,348 | $186K | May 14 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 14,056 | $402K | May 14 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 416 | $13K | Apr 21 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 14,058 | $373K | Apr 15 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does MLYS have?
Mineralys Therapeutics, Inc. (MLYS) has 56 SEC Form 4 filings (160 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for MLYS?
The most recent Form 4 filing for MLYS on Tracefour is dated Oct 20, 2026.
Who is the most active insider at MLYS?
The most active SEC Form 4 filer at MLYS in the rolling window is Chief Medical Officer Rodman David Malcom, with 32 filings.
What is the net insider flow at MLYS over the last 6 months?
Over the trailing 180 days, insiders at MLYS have net sold $12.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MLYS in the current window?
Inside the rolling window, insiders at MLYS bought $8.8M and sold $88.0M based on SEC Form 4 filings.
Can I get alerts for MLYS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Mineralys Therapeutics, Inc. (MLYS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Mineralys Therapeutics, Inc. is in the Healthcare sector.